医療用3Dバイオプリンティングの世界市場規模調査：製品・ソリューション別、技術別、用途別、エンドユーザー別、地域別予測：2022年～2032年

医療用3Dバイオプリンティングの世界市場は、2023年に約12億7,000万米ドルと評価され、予測期間2024-2032年には15.5％以上の健全な成長率で成長すると予測されています。

医療用3Dバイオプリンティングは、組織工学と再生医療に対する革命的なアプローチです。これは、生体材料、細胞、成長因子を層ごとに正確に堆積させ、本来の組織や臓器の複雑な構造や機能を模倣した3次元構造を作り出すものです。この最先端技術は、臓器移植、薬物スクリーニング、疾患モデリング、個別化医療など、幅広い応用に大きな期待を寄せています。世界の医療用3Dバイオプリンティング市場の動向は、異種組成の複雑な組織構造の創出を可能にする多材料・多細胞プリンティングに向かっています。異なる細胞タイプや生体材料をプリンティングプロセスに組み込むことで、研究者は本来の組織や臓器に見られる多様な微小環境を模倣し、構築物の機能性と生物学的関連性を高めることができます。

世界の医療用3Dバイオプリンティング市場は、いくつかの重要な要因に後押しされて力強い成長を遂げています。慢性疾患の蔓延が拡大していることに加え、疾患の進行を研究し、標的療法を開発するためのより正確なモデルが急務となっています。このことが、疾患モデリングや薬剤試験アプリケーションにおける3Dバイオプリンティングの需要を牽引しています。例えば、Advanced Regenerative Manufacturing Institute（ARMI）には、大手メーカー、大学、非営利団体、連邦政府から3億米ドルを超える多額の投資が行われています。この資金は、人工組織や臓器のスケーラブルな製造プロセスの開発を促進することを目的としており、3Dバイオプリンティング技術の進歩に対する業界のコミットメントを反映しています。さらに、世界の医療用3Dバイオプリンティング市場は、3Dバイオプリンティング技術の進歩の高まりと医療研究開発活動への支出の増加によって牽引されています。しかし、組織工学の複雑さと3Dバイオプリンティングシステムに関連する高コストが、2022年から2032年にかけての市場成長を阻害すると予想されています。

医療用3Dバイオプリンティングの世界市場調査で考慮した主要地域は、アジア太平洋地域、北米、欧州、ラテンアメリカ、その他世界の地域です。2023年には、欧州が最大の地域市場となった。この地域の市場成長は、医療用途向け3Dバイオプリンティングの製造技術の進歩とともに、3D Systems CorporationやOrganovo Holdings, Inc.などの主要プレイヤーの存在によって推進されています。さらに、この地域には確立された医療インフラがあり、研究開発（R&D）に多額の投資が行われているため、3Dバイオプリンティングのような最先端技術の進歩や採用に資する環境が醸成されています。こうした要因が相まって、この地域は医療用3Dバイオプリンティング分野の革新と開拓の拠点として位置付けられ、市場の成長を後押ししています。一方、アジア太平洋地域の市場は、予測期間中に最も速い速度で成長すると予想されています。

本レポートに含まれる主な市場プレイヤーは以下の通り：

• 3D Systems Corporation
• デスクトップメタル社
• オルガノボ・ホールディングス
• サイフューズバイオメディカル株式会社
• メドプリンバイオテック GmbH
• アドバンスト・ソリューションズ社
• コルプラント・バイオテクノロジーズ・リミテッド
• レジェマット3D社
• バイオ・コンバージェンス・カンパニー
• シャイニング3D

目次

第1章 世界の医療用3Dバイオプリンティング市場の定義と調査前提条件

• 調査目的
• 市場の定義
• 調査前提条件
  • 包含と除外
  • 制限事項
  • 供給サイドの分析
    • 入手可能性
    • インフラ
    • 規制環境
    • 市場競争
    • 経済性（消費者の視点）
  • 需要サイド分析
    • 規制の枠組み
    • 技術の進歩
    • 環境への配慮
    • 消費者の意識と受容
• 調査手法
• 調査対象年
• 通貨換算レート

第2章 エグゼクティブサマリー

• 医療用3Dバイオプリンティングの世界市場規模＆予測（2022年～2032年）
• 地域別概要
• セグメント別概要
  • 製品・ソリューション別
  • 技術別
  • アプリケーション別
  • エンドユーザー別
• 主要動向
• 景気後退の影響
• アナリストの結論・提言

第3章 医療用3Dバイオプリンティングの世界市場力学

• 市場促進要因
• 市場の課題
• 市場機会

第4章 医療用3Dバイオプリンティングの世界市場産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ
  • ポーター5フォースの影響分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• 破壊的動向
• 業界専門家の視点
• アナリストの結論・提言

第5章 医療用3Dバイオプリンティングの世界市場：製品・ソリューション別市場規模・予測、2022年～2032年

• バイオプリンター
• 消耗品と付属品
• ソフトウェアとサービス

第6章 医療用3Dバイオプリンティングの世界市場規模・予測：技術別、2022年～2032年

• 押出しベースのバイオプリンティング
• インクジェットベースのバイオプリンティング
• レーザー支援バイオプリンティング
• その他

第7章 医療用3Dバイオプリンティングの世界市場規模・用途別予測、2022年～2032年

• 組織工学と再生医療
• 創薬と医薬品開発
• その他

第8章 医療用3Dバイオプリンティングの世界市場規模・予測：エンドユーザー別、2022年～2032年

• バイオテクノロジー・製薬企業
• 学術・研究機関
• その他

第9章 医療用3Dバイオプリンティングの世界市場規模・地域別予測、2022年～2032年

• 北米の医療用3Dバイオプリンティング市場
  • 米国
    • 製品・ソリューションの内訳、市場規模および予測、2022年～2032年
    • 技術の内訳：市場規模＆予測、2022年～2032年
    • 用途の内訳：市場規模＆予測、2022年～2032年
    • エンドユーザーの内訳：市場規模＆予測、2022年～2032年
  • カナダの医療用3Dバイオプリンティング市場
• 欧州の3Dバイオプリンティング市場
  • 英国の医療用3Dバイオプリンティング市場
  • ドイツの医療用3Dバイオプリンティング市場
  • フランス医療用3Dバイオプリンティング市場
  • スペインの医療用3Dバイオプリンティング市場
  • イタリアの医療用3Dバイオプリンティング市場
  • その他欧州の3Dバイオプリンティング市場
• アジア太平洋の3Dバイオプリンティング市場
  • 中国の医療用3Dバイオプリンティング市場
  • インドの医療用3Dバイオプリンティング市場
  • 日本の医療用3Dバイオプリンティング市場
  • オーストラリアの医療用3Dバイオプリンティング市場
  • 韓国の医療用3Dバイオプリンティング市場
  • その他アジア太平洋の医療用3Dバイオプリンティング市場
• ラテンアメリカの医療用3Dバイオプリンティング市場
  • ブラジルの医療用3Dバイオプリンティング市場
  • メキシコの医療用3Dバイオプリンティング市場
  • その他ラテンアメリカの医療用3Dバイオプリンティング市場
• 中東・アフリカの医療用3Dバイオプリンティング市場
  • サウジアラビアの医療用3Dバイオプリンティング市場
  • 南アフリカの医療用3Dバイオプリンティング市場
  • その他中東・アフリカの医療用3Dバイオプリンティング市場

第10章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • 3D Systems Corporation
    • 主要情報
    • 概要
    • 財務（データの入手可能性によります）
    • 製品概要
    • 市場戦略
  • Desktop Metal, Inc.
  • Organovo Holdings, Inc.
  • Cyfuse Biomedical K.K
  • Medprin Biotech GmbH
  • Advanced Solutions, Inc.
  • CollPlant Biotechnologies Ltd
  • REGEMAT 3D S.L
  • The Bio Convergence Company
  • Shining 3D

第11章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • 検証
  • 出版
• 調査属性

LIST OF TABLES

• TABLE 1. Global 3D Bioprinting in Medical market, report scope
• TABLE 2. Global 3D Bioprinting in Medical market estimates & forecasts by Region 2022-2032 (USD Billion)
• TABLE 3. Global 3D Bioprinting in Medical market estimates & forecasts by Products and Solution 2022-2032 (USD Billion)
• TABLE 4. Global 3D Bioprinting in Medical market estimates & forecasts by Technology 2022-2032 (USD Billion)
• TABLE 5. Global 3D Bioprinting in Medical market estimates & forecasts by Application 2022-2032 (USD Billion)
• TABLE 6. Global 3D Bioprinting in Medical market estimates & forecasts by End User 2022-2032 (USD Billion)
• TABLE 7. Global 3D Bioprinting in Medical market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 8. Global 3D Bioprinting in Medical market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 9. Global 3D Bioprinting in Medical market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 10. Global 3D Bioprinting in Medical market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 11. Global 3D Bioprinting in Medical market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 12. Global 3D Bioprinting in Medical market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 13. Global 3D Bioprinting in Medical market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 14. Global 3D Bioprinting in Medical market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 15. Global 3D Bioprinting in Medical market by segment, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 16. Global 3D Bioprinting in Medical market by region, estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 17. U.S. 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 18. U.S. 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 19. U.S. 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 20. Canada 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 21. Canada 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 22. Canada 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 23. UK 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 24. UK 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 25. UK 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 26. Germany 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 27. Germany 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 28. Germany 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 29. France 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 30. France 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 31. France 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 32. Italy 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 33. Italy 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 34. Italy 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 35. Spain 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 36. Spain 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 37. Spain 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 38. RoE 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 39. RoE 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 40. RoE 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 41. China 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 42. China 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 43. China 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 44. India 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 45. India 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 46. India 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 47. Japan 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 48. Japan 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 49. Japan 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 50. Australia 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 51. Australia 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 52. Australia 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 53. South Korea 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 54. South Korea 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 55. South Korea 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 56.
• TABLE 57. RoAPAC 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 58. RoAPAC 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 59. RoAPAC 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 60. Brazil 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 61. Brazil 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 62. Brazil 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 63. Mexico 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 64. Mexico 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 65. Mexico 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 66. RoLA 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 67. RoLA 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 68. RoLA 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 69. Saudi Arabia 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 70. Saudi Arabia 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 71. Saudi Arabia 3D Bioprinting in Medical market estimates & forecasts, 2022-2032 (USD Billion)
• TABLE 72. South Africa 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 73.
• TABLE 74. South Africa 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 75. South Africa 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 76. RoMEA 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 77. RoMEA 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 78. RoMEA 3D Bioprinting in Medical market estimates & forecasts by segment 2022-2032 (USD Billion)
• TABLE 79. List of secondary sources, used in the study of Global 3D Bioprinting in Medical Market.
• TABLE 80. List of primary sources, used in the study of Global 3D Bioprinting in Medical Market.
• TABLE 81. Years considered for the study.
• TABLE 82. Exchange rates considered.

LIST OF FIGURES

• FIG 1. Global 3D Bioprinting in Medical market, research methodology
• FIG 2. Global 3D Bioprinting in Medical market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods.
• FIG 4. Global 3D Bioprinting in Medical market, key trends 2023
• FIG 5. Global 3D Bioprinting in Medical market, growth prospects 2022-2032
• FIG 6. Global 3D Bioprinting in Medical market, porters 5 force model
• FIG 7. Global 3D Bioprinting in Medical market, pestel analysis
• FIG 8. Global 3D Bioprinting in Medical market, value chain analysis
• FIG 9. Global 3D Bioprinting in Medical market by segment, 2022 & 2032 (USD Billion)
• FIG 10. Global 3D Bioprinting in Medical market by segment, 2022 & 2032 (USD Billion)
• FIG 11. Global 3D Bioprinting in Medical market by segment, 2022 & 2032 (USD Billion)
• FIG 12. Global 3D Bioprinting in Medical market by segment, 2022 & 2032 (USD Billion)
• FIG 13. Global 3D Bioprinting in Medical market by segment, 2022 & 2032 (USD Billion)
• FIG 14. Global 3D Bioprinting in Medical market, regional snapshot 2022 & 2032
• FIG 15. North America 3D Bioprinting in Medical market 2022 & 2032 (USD Billion)
• FIG 16. Europe 3D Bioprinting in Medical market 2022 & 2032 (USD Billion)
• FIG 17. Asia pacific 3D Bioprinting in Medical market 2022 & 2032 (USD Billion)
• FIG 18. Latin America 3D Bioprinting in Medical market 2022 & 2032 (USD Billion)
• FIG 19. Middle East & Africa 3D Bioprinting in Medical market 2022 & 2032

Global 3D Bioprinting in Medical Market is valued approximately at USD 1.27 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2024-2032. 3D bioprinting in the medical field represents a revolutionary approach to tissue engineering and regenerative medicine. It involves the precise layer-by-layer deposition of biomaterials, cells, and growth factors to create three-dimensional structures that mimic the complex architecture and functionality of native tissues and organs. This cutting-edge technology holds immense promise for a wide range of applications, including organ transplantation, drug screening, disease modeling, and personalized medicine. Global 3D Bioprinting in Medical Market trends towards multi-material and multi-cellular printing which allows the creation of complex tissue structures with heterogeneous compositions. By incorporating different cell types and biomaterials into the printing process, researchers can mimic the diverse microenvironments found in native tissues and organs, enhancing the functionality and biological relevance of the constructs.

The Global 3D Bioprinting in medical Market is experiencing robust growth, propelled by several key factors. The escalating prevalence of chronic diseases, coupled with the pressing need for more accurate models to study disease progression and develop targeted therapies. This is driving the demand for 3D bioprinting in disease modeling and drug testing applications. For instance, significant investments, exceeding USD 300 million, have been granted to Advanced Regenerative Manufacturing Institute (ARMI) by leading manufacturers, universities, nonprofit organizations, and the federal government. This funding aims to foster the development of scalable manufacturing processes for engineered tissues and organs, reflecting the industry's commitment to advancing 3D bioprinting technologies. Furthermore, Global 3D Bioprinting in medical Market is driven by rising advancements in 3D bioprinting technologies and rising spending in medical research and development activities. However, complexity of tissue engineering and high costs associated with 3D bioprinting systems is expected to stifle the market growth between 2022 and 2032.

The key regions considered for the global 3D Bioprinting in Medical market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Europe was the largest regional market in the market place. The regional market growth is propelled by the presence of key players such as 3D Systems Corporation and Organovo Holdings, Inc., alongside advancements in the manufacturing technology of 3D bioprinting for medical applications. Furthermore, the region has well-established healthcare infrastructure and substantial investment in research and development (R&D), fostering an environment conducive to the advancement and adoption of cutting-edge technologies like 3D bioprinting. These factors collectively drive market growth, positioning the region as a hub for innovation and development in the field of medical 3D bioprinting. The market in Asia Pacific, on the other hand, is expected to grow at the fastest rate over the forecast period.

Major market player included in this report are:

• 3D Systems Corporation
• Desktop Metal, Inc.
• Organovo Holdings, Inc.
• Cyfuse Biomedical K.K
• Medprin Biotech GmbH
• Advanced Solutions, Inc.
• CollPlant Biotechnologies Ltd
• REGEMAT 3D S.L
• The Bio Convergence Company
• Shining 3D

The detailed segments and sub-segment of the market are explained below:

By Products and Solution

• Bioprinters
• Consumables and accessories
• Software and services

By Technology

• Extrusion based bioprinting
• Inkjet based bioprinting
• Laser assisted bioprinting
• Others

By Application

• Tissue engineering and regenerative medicine
• Drug discovery and development
• Others

By End User

• Biotechnology and pharmaceutical companies
• Academic and research institutes
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global 3D Bioprinting in Medical Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global 3D Bioprinting in Medical Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Products and Solutions
  • 2.3.2. By Technology
  • 2.3.3. By Application
  • 2.3.4. By End User
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global 3D Bioprinting in Medical Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global 3D Bioprinting in Medical Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global 3D Bioprinting in Medical Market Size & Forecasts by Products and Solutions 2022-2032

• 5.1. Bioprinters
• 5.2. Consumables and accessories
• 5.3. Software and services

Chapter 6. Global 3D Bioprinting in Medical Market Size & Forecasts by Technology 2022-2032

• 6.1. Extrusion based bioprinting
• 6.2. Inkjet based bioprinting
• 6.3. Laser assisted bioprinting
• 6.4. Others

Chapter 7. Global 3D Bioprinting in Medical Market Size & Forecasts by Application 2022-2032

• 7.1. Tissue engineering and regenerative medicine
• 7.2. Drug discovery and development
• 7.3. Others

Chapter 8. Global 3D Bioprinting in Medical Market Size & Forecasts by End User 2022-2032

• 8.1. Biotechnology and pharmaceutical companies
• 8.2. Academic and research institutes
• 8.3. Others

Chapter 9. Global 3D Bioprinting in Medical Market Size & Forecasts by Region 2022-2032

• 9.1. North America 3D Bioprinting in Medical Market
  • 9.1.1. U.S. 3D Bioprinting in Medical Market
    • 9.1.1.1. Products and Solution breakdown size & forecasts, 2022-2032
    • 9.1.1.2. Technology breakdown size & forecasts, 2022-2032
    • 9.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 9.1.1.4. End User breakdown size & forecasts, 2022-2032
  • 9.1.2. Canada 3D Bioprinting in Medical Market
• 9.2. Europe 3D Bioprinting in Medical Market
  • 9.2.1. U.K. 3D Bioprinting in Medical Market
  • 9.2.2. Germany 3D Bioprinting in Medical Market
  • 9.2.3. France 3D Bioprinting in Medical Market
  • 9.2.4. Spain 3D Bioprinting in Medical Market
  • 9.2.5. Italy 3D Bioprinting in Medical Market
  • 9.2.6. Rest of Europe 3D Bioprinting in Medical Market
• 9.3. Asia-Pacific 3D Bioprinting in Medical Market
  • 9.3.1. China 3D Bioprinting in Medical Market
  • 9.3.2. India 3D Bioprinting in Medical Market
  • 9.3.3. Japan 3D Bioprinting in Medical Market
  • 9.3.4. Australia 3D Bioprinting in Medical Market
  • 9.3.5. South Korea 3D Bioprinting in Medical Market
  • 9.3.6. Rest of Asia Pacific 3D Bioprinting in Medical Market
• 9.4. Latin America 3D Bioprinting in Medical Market
  • 9.4.1. Brazil 3D Bioprinting in Medical Market
  • 9.4.2. Mexico 3D Bioprinting in Medical Market
  • 9.4.3. Rest of Latin America 3D Bioprinting in Medical Market
• 9.5. Middle East & Africa 3D Bioprinting in Medical Market
  • 9.5.1. Saudi Arabia 3D Bioprinting in Medical Market
  • 9.5.2. South Africa 3D Bioprinting in Medical Market
  • 9.5.3. Rest of Middle East & Africa 3D Bioprinting in Medical Market

Chapter 10. Competitive Intelligence

• 10.1. Key Company SWOT Analysis
• 10.2. Top Market Strategies
• 10.3. Company Profiles
  • 10.3.1. 3D Systems Corporation
    • 10.3.1.1. Key Information
    • 10.3.1.2. Overview
    • 10.3.1.3. Financial (Subject to Data Availability)
    • 10.3.1.4. Product Summary
    • 10.3.1.5. Market Strategies
  • 10.3.2. Desktop Metal, Inc.
  • 10.3.3. Organovo Holdings, Inc.
  • 10.3.4. Cyfuse Biomedical K.K
  • 10.3.5. Medprin Biotech GmbH
  • 10.3.6. Advanced Solutions, Inc.
  • 10.3.7. CollPlant Biotechnologies Ltd
  • 10.3.8. REGEMAT 3D S.L
  • 10.3.9. The Bio Convergence Company
  • 10.3.10. Shining 3D

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes